Hints and tips:
Showing results for Actavis Laboratories UT Inc.
...Actavis Holdco U.S., Inc.; Actavis Pharma, Inc.; Ascend Laboratories, LLC; Apotex Corp.; Dr....
...Actavis acquired Allergan, which makes the Botox cosmetic, last year and adopted its name after the deal closed....
...The tie-up with Actavis also paved the way for further dealmaking....
...But Allergan’s combination last year with Actavis — itself newly enlarged through a dizzying series of deals — created a company that fitted his two main criteria....
...So could Mr Saunders be about to put on his laboratory coat and buy a company such as Biogen or AbbVie? “It’s possible....
...Others include Actavis, which bought Allergan, the maker of Botox, last year for $66bn and has since adopted the Allergan name....
...Most recently it bought Botox maker Allergan for $70bn and ditched the company’s previous name, Actavis....
...He says that of the world’s top 20 best-selling drugs, just “two or three were truly discovered in the laboratory”, with the rest being new takes on existing compounds....
...resisted Teva’s advances, preferring instead to pursue its own $33bn hostile bid for Perrigo, a Dublin-based generic drugmaker, just two months after completing a $5.3bn acquisition of products from Abbott Laboratories...
...The frenzy began when Actavis bought Forest Laboratories for $25bn early last year and has continued ever since, involving almost every big drugmaker and many supporting actors from the biotech and medical...
...For Mr Pearson, modern drugmaking is stuck in the past, clinging to a postwar business model where armies of white-coated scientists toil away in laboratories....
...It bought Watson Pharmaceuticals for $6bn (2012), Ireland-domiciled Warner Chilcott for $9bn (2013) and Forest Laboratories for $25bn (2014)....
...Actavis had stopped selling the pill and told doctors to move patients to a newer version, Namenda XR....
...The company had five drug applications approved by the US regulator last year, most of which originated in its own laboratories, he says....
...There probably are,” says Brent Saunders, the chief executive of Actavis who engineered the biggest takeover of 2014 — the $70.5bn acquisition of Botox maker Allergan....
...Actavis, the highly acquisitive Dublin-based drugs maker, has agreed to buy New York’s Forest Laboratories for $25bn, its biggest purchase to date....
...So it makes sense that Actavis shares rose 8 per cent on news that it would pay $7bn in cash and issue $18.5bn worth of its shares (a 51 per cent increase in the share count) to buy Forest Laboratories....
...The $25bn purchase of Forest Laboratories, announced on Tuesday, is by far the largest transaction he has overseen so far....
...Partly because his four-year campaign of pressure on the drugmaker Forest Laboratories came to lucrative fruition in a $25bn sale to Actavis....
...Analysts at Goldman said the acquisitive Dublin-based company would see a “substantial” sales and profit improvement if it is able to complete its $25bn buyout of New York’s Forest Laboratories....
...FT EVENING ROUND-UP Actavis buys Forest Laboratories for $25bn: “Actavis, the highly acquisitive Dublin-based drugs maker, has agreed to buy New York’s Forest Laboratories for $25bn, its biggest purchase...
...Actavis, for example, in February agreed to pay $25bn for Forest Laboratories of the US, giving the Dublin-based generics maker access to a range of specialist drugs....
...Most of the activity has been in the US, including last week’s $25bn acquisition of New York-based Forest Laboratories by Actavis, one of the world’s biggest generic drugmakers....
...Other big deals in the sector have included the $25bn takeover of Forest Laboratories by Actavis in February, another deal that involved a generic drugmaker moving into higher-value branded products....
...Companies including Horizon Pharma, Perrigo, Actavis, Alkermes, Jazz Pharmaceuticals, Covidien, Forest Laboratories and Endo Health Solutions have moved to Ireland, in deals expected to cut companies’ overall...
International Edition